You are here

12-06-2019 | © picture

ERC research lends an ear to the voices heard by schizophrenia patients

The ERC-funded ONOFF project is building upon previous efforts to better understand auditory hallucinations (AH) in patients with schizophrenia. Its results could lead to new cognitive and pharmacological treatments.

29-05-2019 | © picture

Can we grow an artificial retina?

Diseases affecting the retina cause one quarter of worldwide blindness. To date, there are no treatments to restore lost retinal cells and visual function, making it urgent to find new therapeutic approaches. Can stem cells be the solution? Prof. Majlinda Lako aims at growing artificial replicas of the human retina using stem cells.

26-11-2018 | © picture

Eyeing up food supplements for healthy vision

Key nutrients can improve vision both in ageing and in healthy eyes, according to EU-funded research. Doctors are now prescribing supplements of these nutrients, while the researchers are investigating other possible health benefits.

23-10-2018 | © picture

AI all around us

Agnieszka Wykowska is a senior researcher of the Social Cognition in Human-Robot Interaction at the Italian Institute of Technology (Istituto Italiano di Tecnologia) in Genova, Italy. In 2016 she has been awarded an ERC Starting Grant for her project “Intentional Stance for Social Attunement” whose goal is to investigate if humans are ready to engage in social interactions with humanoid robots. Dr Wykowska will present her findings at the ERC's conference Frontier Research and Artificial Intelligence.  

28-09-2018 | Image: ©istockphotos

Making sense of commitment

An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.

27-08-2018 | © picture

From basic research to clinical medicine: stimulating the natural growth of heart blood vessels

At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.

20-08-2018 | iStock

Artificial heart valves: synthetic polymer coatings could reduce complications in patients

More than 100 million people worldwide suffer from valvular heart disease, affecting one or more of the heart’s four valves and causing breathlessness, chest pain, dizziness and fainting. If severe valvular heart disease is not properly treated, chances of surviving decrease, especially in the elderly. The only effective therapy is heart valve replacement, which may entail some risks and lead to revision surgeries. What can be done to improve safety and durability of artificial heart valves? 

29-06-2018 | © Paul Gissen

Organoids to treat liver diseases

Cell transplantation is a promising new approach for organ regeneration in disease or after injury. To support the differentiation of hepatocytes from stem cells, European researchers developed ex vivo organoids which precisely mimic liver architecture.

29-05-2018 | © picture

Shut up and heal - possible strategy to cure sick livers

'Silent killers'. This is how liver diseases are often described. But, are they really that silent? ERC grantee Mathieu Vinken, a pharmacist by training and worldwide expert in toxicology based at Vrije Universiteit Brussel (VUB), has just proven the contrary.

11-10-2017 | © Angela Erhard

The baby's brain, as never seen before

For the first time ever, a team of scientists and clinicians led by the EU-funded researcher Mickael Tanter has managed to record the brain activity of a premature new-born baby during resting and during an epileptic seizure. Using a non-invasive ultrasound technology, this world premiere is a real game changer for researchers and the medical profession, offering a massive range of applications in neuroimaging and beyond. It is published today in Science Translational Medicine.